Patents/Inventors

Martin Maier

Cambridge, MAUS22 patents

25 Patents

US123970132025
Extrahepatic Delivery
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123850432025
Modified Double-stranded RNA Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123850442025
Modified Double-stranded RNA Agents
Alnylam Pharmaceuticals, Inc.
0 cites
US123785532025
Modified Double-stranded RNA Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123647622025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123503382025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123433982025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122905732025
Modified Rnai Agents
Alnylam Pharmaceuticals, Inc.
0 cites
US122759382025
Modified RNA Agents with Reduced Off-target Effect
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122472032025
Modified RNA Agents with Reduced Off-target Effect
Alnylam Pharmaceuticals, Inc.
0 cites
US122397092025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122410642025
REVERSIR™ Compounds
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122216072025
Multi-targeted Single Entity Conjugates
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US121687672024
Modified Double-stranded RNA Agents
Alnylam Pharmaceuticals, Inc.
0 cites
US120594682024
Carbohydrate Conjugates as Delivery Agents for Oligonucleotides
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US120182602024
Tunable Reversir™ Compounds
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US120050742024
Extrahepatic Delivery
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116791582023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116666532023
Carbohydrate Conjugates as Delivery Agents for Oligonucleotides
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116334792023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116334802023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116126572023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US115979322023
Chirally-enriched Double-stranded RNA Agents
Alnylam Pharmaceuticals, Inc.
0 cites
US115902292023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US115491092023
Modified Double-stranded RNA Agents
Alnylam Pharmaceuticals, Inc.
0 cites